Intravenous Placebo
Intravenous Placebo is a pharmaceutical drug with 36 clinical trials. Currently 4 active trials ongoing. Historical success rate of 92.6%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
8
Mid Stage
17
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.2%
25 of 29 finished
13.8%
4 ended early
4
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
Clinical Trials (36)
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.
A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis
Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users
ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
A Preliminary Study to Evaluate PF-07264660 in Healthy Participants
Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI
Lidocaine And Neuromonitoring in Thyroid Surgery
Evaluation of N1539 Following Major Surgery
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects
Effect of Intravenous Metoprolol Combining RIC on Myocardial Protection in STEMI Patients
Acute Ischemic Stroke Interventional Study
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 36